{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "A study of medical reporting on local TV news programs has found much of the coverage wanting at best, and downright misleading at worst.", "headline": {"main": "Patterns:  Health Experts Criticize TV's Medical Coverage", "kicker": "Vital Signs", "print_headline": "Health Experts Criticize TV's Medical Coverage", "content_kicker": "Vital Signs"}, "abstract": null, "print_page": "6", "word_count": "222", "_id": "54b34e9179881019b02c1ffa", "snippet": "A study of medical reporting on local TV news programs has found much of the coverage wanting at best, and downright misleading at worst.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/03/14/health/14prac.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Television", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "2", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Eric", "lastname": "NAGOURNEY"}], "original": "By ERIC NAGOURNEY"}, "document_type": "article", "pub_date": "2006-03-14T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "The health news of recent weeks could prompt even a stalwart defender of preventive medicine like me to abandon hope.", "headline": {"main": "Fine Print Sends Clear Message: Stay the Course", "kicker": "Personal Health", "print_headline": "Fine Print Sends Clear Message: Stay the Course", "content_kicker": "Personal Health"}, "abstract": null, "print_page": "7", "word_count": "1218", "_id": "54b34e5879881019b02c1ff4", "snippet": "The health news of recent weeks could prompt even a stalwart defender of preventive medicine like me to abandon hope.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/03/14/health/14brod.html", "multimedia": [{"subtype": "thumbnail", "url": "images/2006/03/13/science/14brod.75.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2006/03/13/science/14brod.75.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Medicine and Health", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Vitamins", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Women", "is_major": "N", "rank": "3", "name": "subject"}], "byline": {"person": [{"firstname": "Jane", "middlename": "E.", "lastname": "BRODY", "rank": 1, "role": "reported", "organization": ""}], "original": "By JANE E. BRODY"}, "document_type": "article", "pub_date": "2006-03-14T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Health&Fitness", "lead_paragraph": "A new study of medical reporting on local television news programs, a major source of health information for Americans, has found much of the coverage wanting at best, and downright misleading at worst. Writing in The American Journal of Managed Care, researchers from the University of Michigan chronicled an array of problems with the coverage. The researchers, led by Dr. James M. Pribble, examined one month of local news programming, October 2002, from 122 stations in the top 50 markets.", "headline": {"main": "Health Experts Criticize TV's Medical Coverage", "kicker": "VITAL SIGNS: PATTERNS"}, "abstract": "Dr James M Pribble of University of Michigan leads study on television coverage of medical news; research, which is published in American Journal of Managed Care, points to limited time frame of television spots as primary cause of incomplete and sometimes misleading information (S)", "print_page": "6", "word_count": 225, "_id": "4fd26aaf8eb7c8105d822140", "snippet": "A new study of medical reporting on local television news programs, a major source of health information for Americans, has found much of the coverage wanting at best, and downright misleading at worst.     Writing in The American Journal of Managed...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9C05EFDA1031F937A25750C0A9609C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "PRIBBLE, JAMES M"}, {"name": "organizations", "value": "AMERICAN JOURNAL OF MANAGED CARE"}, {"name": "organizations", "value": "UNIVERSITY OF MICHIGAN"}, {"name": "subject", "value": "TELEVISION"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Eric", "rank": 1, "lastname": "Nagourney"}], "original": "By Eric Nagourney"}, "document_type": "article", "pub_date": "2006-03-14T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "On Feb. 3, Joyce Elkins filled a prescription for a two-week supply of nitrogen mustard, a decades-old cancer drug used to treat a rare form of lymphoma. The cost was $77.50. On Feb. 17, Ms. Elkins, a 64-year-old retiree who lives in Georgetown, Tex., returned to her pharmacy for a refill. This time, following a huge increase in the wholesale price of the drug, the cost was $548.01.", "headline": {"main": "A Cancer Drug's Big Price Rise Disturbs Doctors and Patients"}, "abstract": "Merck & Co sold rights to manufacture and market slow-selling cancer drugs nitrogen mustard, or Mustargen, and Cosmegen to Ovation Pharmaceuticals last August; Ovation stunned doctors and patients by raising wholesale price of Mustargen roughly tenfold in February and that of Cosmegen even more, saying increases were needed to pay for manufacturing facilities for drugs; doctors see trend in soaring prices of cancer drugs and tendency for prices to have little relation to cost of development; graph; photos (L)", "print_page": "1", "word_count": "1666", "_id": "4fd267188eb7c8105d81c85d", "snippet": "The price of cancer medicines is soaring, but the increases tend to have little relation to the cost of developing or making the drugs.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/03/12/business/12price.html", "multimedia": [{"url": "images/2006/03/12/business/price.75.jpg", "subtype": "thumbnail", "legacy": {"hasthumbnail": "Y", "thumbnailheight": 75, "thumbnail": "images/2006/03/12/business/price.75.jpg"}, "type": "image", "height": 75}], "subsection_name": null, "keywords": [{"name": "organizations", "value": "OVATION PHARMACEUTICALS"}, {"name": "organizations", "value": "MERCK & CO"}, {"name": "subject", "value": "NITROGEN MUSTARD (DRUG)"}, {"name": "subject", "value": "ADVERTISING AND MARKETING"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "COSMEGEN (DRUG)"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "FACTORIES AND INDUSTRIAL PLANTS"}, {"name": "subject", "value": "MUSTARGEN (DRUG)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Alex", "lastname": "BERENSON"}], "original": "By ALEX BERENSON"}, "document_type": "article", "pub_date": "2006-03-12T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "New Jersey Weekly Desk", "lead_paragraph": "''SANICART WIPE,'' says the little white canister positioned by the sliding front doors at the ShopRite. ''Disinfects Shopping Car Handles and Child Seats.'' People are grabbing them. First two older shoppers. Then a woman from Boonton. ''These handles,'' she says, her face drawing into an ewww. ''Everybody's touching them.''", "headline": {"main": "Gloves On? Then It's Safe To Read This", "kicker": "JERSEY"}, "abstract": null, "print_page": "1", "word_count": 699, "_id": "4fd2ab7f8eb7c8105d89846c", "snippet": "''SANICART WIPE,'' says the little white canister positioned by the sliding front doors at the ShopRite. ''Disinfects Shopping Car Handles and Child Seats.''     People are grabbing them. First two older shoppers. Then a woman from Boonton. ''These...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=950CE3D61231F931A25750C0A9609C8B63", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Paula", "rank": 1, "lastname": "Span"}], "original": "By Paula Span"}, "document_type": "article", "pub_date": "2006-03-12T00:00:00Z", "section_name": "New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "Magazine", "lead_paragraph": "Like most American women who give birth to a severely handicapped child, Donna Branca became pregnant with A.J. well before the age of 35. Had she been older, her doctors would almost certainly have recommended amniocentesis to screen for genetic disorders. But she was 31, so they did not, despite the fact that she had an unusual pregnancy. Branca bled during her first trimester, a possible indication of birth defects, and at her midterm sonogram, when she was 20 weeks pregnant, her fetus looked smaller than it should have based on when her doctors originally presumed she conceived. Branca had not gained much weight, either, but her doctors -- whom she is barred from identifying, by a legal settlement -- saw no cause for alarm. ''Looking back now, of course, it's easy to say I should have asked more questions or maybe been a little more concerned,'' she told me last fall, sitting in her grassy backyard in Orangeburg, 20 miles north of Manhattan. Branca is a pretty woman, dark and compact, with a winning suburban New York accent. She glanced at A.J., a 6-year-old with a head of dark curls and the mental capacity of a 6-month-old. Her 3-year-old twins from a subsequent pregnancy ran around collecting acorns.", "headline": {"main": "A Wrongful Birth?"}, "abstract": "Elizabeth Weil article on wrongful-birth lawsuits being brought by parents of severely disabled children against obstetricians whom they accuse of failing to provide kind of prenatal screening and care that would have allowed them to consider having abortions; says lawsuits reflect relatively new belief that people should have right to choose which babies are born; focuses on lawsuit brought by Donna and Anthony Branca of Orangeburg, NY, who won multimillion-dollar settlement set aside for care of a son born with Wolf-Hirschhorn syndrome; photo (L)", "print_page": "48", "word_count": 5046, "_id": "4fd250978eb7c8105d7f3f82", "snippet": "Legally, and morally, what does it mean to say that a child should not have existed?", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/03/12/magazine/312wrongful.1.html", "multimedia": [{"url": "images/2006/03/08/magazine/12wrongful.75.jpg", "subtype": "thumbnail", "legacy": {"hasthumbnail": "Y", "thumbnailheight": 75, "thumbnail": "images/2006/03/08/magazine/12wrongful.75.jpg"}, "type": "image", "height": 75}, {"subtype": "tiny_thumb", "legacy": {"tinythumbwidth": 55, "tinythumbheight": 55, "hastinythumb": "Y"}, "type": "image", "width": 55, "height": 55}], "subsection_name": null, "keywords": [{"name": "persons", "value": "BRANCA, ATHONY"}, {"name": "persons", "value": "BRANCA, DONNA"}, {"name": "subject", "value": "BIRTH DEFECTS"}, {"name": "subject", "value": "WOLF-HIRSHHORN SYNDROME"}, {"name": "subject", "value": "ABORTION"}, {"name": "subject", "value": "PREGNANCY AND OBSTETRICS"}, {"name": "subject", "value": "SUITS AND LITIGATION"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Elizabeth", "rank": 1, "lastname": "Weil"}], "original": "By Elizabeth Weil"}, "document_type": "article", "pub_date": "2006-03-12T00:00:00Z", "section_name": "Magazine"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "A ballot proposal promoting embryonic stem cell research is turning conservatives against one another in Missouri and threatening to tear apart the state Republican Party at the height of its modern-day influence. The measure -- sponsored by a coalition of medical groups, researchers, businesses and advocates for patients -- would make Missouri the only state besides California to include the right to stem cell research in its state constitution.", "headline": {"main": "Stem Cell Proposal Splits Missouri G.O.P."}, "abstract": "Ballot proposal promoting embryonic stem cell research would make Missouri only state after California to include right to stem cell research in its Constitution; debate over measure is breaking up successful Republican partnership of business interests and religious conservatives; measure is direct response to effort by Missouri lawmakers to make cloning of embryonic stem cells illegal; proposal appears certain to get enough petition signatures to make it onto ballot in November (M)", "print_page": "16", "word_count": 699, "_id": "4fd24fdb8eb7c8105d7f32c5", "snippet": "A ballot proposal promoting embryonic stem cell research is turning conservatives against one another in Missouri.", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/03/12/national/12stemcell.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "MISSOURI"}, {"name": "glocations", "value": "CALIFORNIA"}, {"name": "organizations", "value": "REPUBLICAN PARTY"}, {"name": "subject", "value": "STEM CELLS"}, {"name": "subject", "value": "FETAL TISSUE"}, {"name": "subject", "value": "ELECTION ISSUES"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "CONSTITUTIONS"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "REFERENDUMS"}], "byline": null, "document_type": "article", "pub_date": "2006-03-12T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Joseph A. Brocato's weekly self-injections of a drug to treat hepatitis C left him so feverish and fatigued, he said, he often thought of quitting. He didn't, thanks to a nurse who urged him by phone to stay the course. The nurse, Colleen Dinsdale, did not work for Mr. Brocato's doctor. Rather, Ms. Dinsdale was paid by the drug's maker, Roche, and its distributor, McKesson. Each month that Mr. Brocato took the drug, Pegasys, and its companion pill, ribavirin, meant $3,000 in sales -- most of it paid by his insurance company. His share was a $50 co-payment.", "headline": {"main": "Take Your Pills, All Your Pills; Drug Makers Nag Patients to Stay the Course"}, "abstract": "Drug companies use nurses as part of sales and marketing strategy to urge patients to use medication as directed; pharmaceutical industry loses billions of dollars annually because people do not take drugs as often or as long as prescribed; studies show that not taking medicines as prescribed can cause patients to develop serious, costly complications; medical professionals worry about consumer's privacy or destroying trust of medical community; experts are concerned about industry motives and how brand loyalty effects programs; photo; graph (M)", "print_page": "1", "word_count": 1444, "_id": "4fd250978eb7c8105d7f3f58", "snippet": "A \"take-your-medicine\" program is part of a marketing strategy that is gaining urgency for drug makers experiencing slowing sales.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/03/11/business/media/11finish.html", "multimedia": [{"url": "images/2006/03/11/business/11fini75.jpg", "subtype": "thumbnail", "legacy": {"hasthumbnail": "Y", "thumbnailheight": 75, "thumbnail": "images/2006/03/11/business/11fini75.jpg"}, "type": "image", "height": 75}], "subsection_name": null, "keywords": [{"name": "subject", "value": "SALES"}, {"name": "subject", "value": "NURSING AND NURSES"}, {"name": "subject", "value": "ADVERTISING AND MARKETING"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "CONSUMER PROTECTION"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "PRIVACY"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Andrew", "rank": 1, "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2006-03-11T00:00:00Z", "section_name": "Health; Business"}], "meta": {"hits": 8, "offset": 0, "time": 42}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}